Abstract
OBJECTIVE:
To study the relationships between leptin, soluble leptin receptor (sOB-R), and insulin resistance in obese children before and after weight reduction.
METHODS:
We determined fasting serum leptin, sOB-R, and insulin resistance index (Homeostasis model assessment (HOMA)) in 36 obese children at baseline and 1 y later and compared them to 72 lean children matched for age, gender, and pubertal stage. The changes of leptin (Δleptin) and sOB-R (ΔsOB-R) over the 1 y period were correlated to the changes of HOMA (ΔHOMA), the changes of weight status, and the changes of percentage body fat (Δ%BF) based on skinfold measurements. Multiple linear regression analyses were conducted for the dependent variables Δleptin and ΔsOB-R, including ΔBMI and ΔHOMA as independent variables adjusted for age, gender, and pubertal stage. Changes of leptin and sOB-R levels were analyzed in 11 obese children after they had lost weight substantially (decrease SDS-BMI>0.5) and compared to 11 obese children without substantial weight loss matched for age, gender, and pubertal stage.
RESULTS:
Obese children showed significantly (P<0.001) higher leptin and lower sOB-R levels. Δleptin correlated significantly to ΔSDS-BMI (r=0.28, P<0.05), Δ%BF (r=0.44, P<0.05), and ΔHOMA (r=0.42, P<0.01), while ΔsOB-R correlated significantly to ΔSDS-BMI (r=−0.42, P<0.01) and Δ%BF (r=−0.47, P<0.01), but not to ΔHOMA. In contrast to ΔsOB-R, Δleptin correlated significantly to ΔHOMA (P=0.02) in multiple linear regression analysis. Substantial weight loss led to a significant increase in sOB-R (P=0.02) and to a decrease in HOMA (P=0.02). In children without substantial weight loss, there were no changes in sOB-R, while HOMA (P=0.04) and leptin (P=0.02) increased significantly.
CONCLUSIONS:
The decrease of sOB-R and the increase of leptin levels in obese children normalized after weight loss. Therefore, these changes are consequences rather than the cause of overweight. In contrast to sOB-R, leptin levels are associated with insulin resistance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Müller J, Skakkebaek NE, Heiman ML, Birkett M, Attanasio AM, Kiess W, Rascher W . Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 1997; 82: 2904–2910.
Bluher S, Mantzoros CS . The role of leptin in regulating neuroendocrine function in humans. J Nutr 2004; 134: 2469S–2474S.
Targalia LA, Dembski M, Weng Y, Deng N, Culepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI . Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263–1271.
Kratzsch J, Lammert A, Bottner A, Seidel B, Mueller G, Thierry J, Hebebrand J, Kiess W . Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. J Clin Endocrinol Metab 2002; 87: 4587–4594.
Lammert A, Kiess W, Glasow A, Kratzsch J . Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 2001; 283: 982–988.
Huang L, Wang Z, Li C . Modulation of circulating leptin levels by its soluble receptor. J Biol Chem 1995; 276: 6343–6349.
Zastrow O, Seidel B, Kiess W, Thierry J, Keller E, Böttner A, Kratzsch . The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data. Int J Obes Relat Metab Disorder 2003; 27: 1472–1478.
Chan JL, Blüher S, Yiannakouris N, Suchard MA, Kratzsch J, Mantzoros C . Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids and leptin. Diabetes 2002; 51: 2105–2112.
Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, Becker GW, Bowsher RR, Stephens TW, Caro JF . Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996; 98: 1277.
Landt M, Horowitz JF, Coppack SW, Klein S . Effect of short-term fasting on free and bound leptin concentrations in lean and obese women. J Clin Endocrinol Metab 2001; 86: 3768–3771.
Zimmet P, Boyko EJ, Collier GR, de Courten M . Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann NY Acad Sci 1999; 892: 25–44.
Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N . Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 1004: 3052–3056.
Alberti KG, Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.
Ogawa T, Hirose H, Yamamoto Y, Nishikai K, Miyashita K, Nakamura H, Saito I, Saruta T . Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population. Metabolism 2004; 53: 879–885.
Sandhofer A, Laimer M, Ebenbichler CF, Kaser S, Paulweber B, Patsch JR . Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 2003; 11: 760–768.
Van Dielen F, Veer C, Buurman W, Greve JM . Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 2002; 87: 1708–1716.
Laimer M, Ebenbichler CF, Kaser S, Sandhofer A, Weiss H, Nehoda H, Aigner F, Patsch JR . Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin. Obes Res 2002; 10: 597–601.
Mann DR, Johnson AOK, Gimpel T, Castracane VD . Changes in circulating leptin, leptin receptor, and gonadal hormones from infancy until advanced age in humans. J Clin Endocrinol Metab 2003; 88: 3339–3345.
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH . Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240–1243.
Kromeyer-Hauschild K, Wabitsch M, Geller F, Ziegler A, Geiß HC, Hesse V, Hippel V, Jaeger U, Johnsen D, Kiess W, Korte W, Kunze D, Menner K, Müller G, Müller M, Niemann-Pilatus A, Remer Th, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Hebebrand J . Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001; 149: 807–818.
Cole TJ . The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44: 45–60.
Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, Bemben DA . Skinfold equations for estimation of body fatness in children and youth. Hum Biol 1988; 60: 709–723.
Kratzsch J, Berthold A, Lammert A, Reuter W, Keller E, Kiess W . A rapid, quantitative immunofunctional assay for measuring human leptin. Horm Res 2002; 57: 127–132.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Reinehr T, Kersting M, Alexy U, Andler W . Long-term follow-up of overweight children: after training, after a single consultation session and without treatment. J Pediatr Gastroenterol Nutr 2003; 37: 72–74.
Reinehr T, Brylak K, Alexy U, Kersting M, Andler W . Predictors to success in outpatient training in obese children and adolescents. Int J Obes Relat Metab Disord 2003; 27: 1087–1092.
Reinehr T, Andler W . Changes in the atherogenic risk- factor profile according to degree of reduction of overweight. Arch Dis Child 2004; 89: 419–422.
Reinehr T, Kiess W, Kapellen T, Andler W . Insulin sensitivity in obese children and adolescents according to degree of weight loss. Pediatrics 2004; 114: 1569–1573.
Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-Zacas D, Mantzoros CS . Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin in healthy humans. J Clin Endocrinol Metab 2003; 88: 1730–1736.
Uotani S, Bjoerbaek C, Tornoe J, Flier JS . Functional properties of leptin receptor isoforms: internalisation and degradation of leptin and ligand-induced receptor downregulation. Diabetes 1999; 48: 279–286.
Hikita M, Bujo H, Hirayama S, Takahashi K, Morisaki N, Saito Y . Differential regulation of leptin receptor expression by insulin and leptin in neuroblastoma cells. Biochem Biophys Res Commun 2000; 271: 703–709.
Lahlou N, Clement K, Carel JC, Vaisse C, Lotton C, Le Bihan Y, Basdevant A, Lebouc Y, Froguel P, Roger M, Guy-Grand B . Soluble leptin receptor in serum of subjects with complete resistance to leptin. Relation to fat mass. Diabetes 2000; 49: 1347–1352.
Gavrilova O, Barr V, Marcus-Samuels B, Reitmann M . Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor. J Biol Chem 1997; 272: 30546–30551.
Shimizu H, Shimomura K, Negishi M, Masunaga M, Uehara Y, Sato N, Shimomura Y, Kasai K, Mori M . Circulating concentrations of soluble leptin receptor: influence of menstrual cycle and diet therapy. Nutrition 2002; 18: 309–312.
Ogier V, Ziegler O, Méjean L, Nicolas JP, Stricker-Kongrad A . Obesity is associated with decreasing levels of the circulating soluble leptin receptor in humans. Int J Obes 2002; 26: 496–503.
Jequir E . Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 2002; 967: 379–388.
Wallace TM, Matthews DR . The assessment of insulin resistance in man. Diabetes Med 2002; 19: 527–534.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reinehr, T., Kratzsch, J., Kiess, W. et al. Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children. Int J Obes 29, 1230–1235 (2005). https://doi.org/10.1038/sj.ijo.0803027
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0803027
Keywords
This article is cited by
-
Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren
Endocrine (2017)
-
Changes in the serum metabolite profile in obese children with weight loss
European Journal of Nutrition (2015)
-
Correlation between reduction of superior interventricular groove epicardial fat thickness and improvement of insulin resistance after weight loss in obese men
Diabetology & Metabolic Syndrome (2014)
-
Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets
BMC Pediatrics (2013)
-
Lifestyle intervention in childhood obesity: changes and challenges
Nature Reviews Endocrinology (2013)